Zynex Inc (ZYXI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zynex Inc (ZYXI) has a cash flow conversion efficiency ratio of 0.152x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-6.31 Million) by net assets ($-41.37 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Zynex Inc balance sheet quality to measure how much of total assets are equity-financed.
Zynex Inc - Cash Flow Conversion Efficiency Trend (2000–2024)
This chart illustrates how Zynex Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Zynex Inc to evaluate the quality of earnings relative to operating cash generation.
Zynex Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zynex Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jet.AI Inc.
NASDAQ:JTAI
|
0.031x |
|
Earthworks Industries Inc
V:EWK
|
0.003x |
|
Synergy CHC Corp. Common Stock
NASDAQ:SNYR
|
0.080x |
|
Electromagnetic Geoservices ASA
OL:EMGS
|
-0.107x |
|
Aminex PLC
STU:DOP
|
-0.014x |
|
Redstone Resources Ltd
AU:RDS
|
-0.017x |
|
Kiplin Metals Inc
V:KIP
|
-0.072x |
|
Comanche International Public Company Limited
BK:COMAN
|
-0.002x |
Annual Cash Flow Conversion Efficiency for Zynex Inc (2000–2024)
The table below shows the annual cash flow conversion efficiency of Zynex Inc from 2000 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Zynex Inc.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $35.71 Million | $12.72 Million | 0.356x | -7.45% |
| 2023-12-31 | $46.13 Million | $17.76 Million | 0.385x | +85.82% |
| 2022-12-31 | $66.36 Million | $13.75 Million | 0.207x | +120.37% |
| 2021-12-31 | $73.92 Million | $6.95 Million | 0.094x | +553.35% |
| 2020-12-31 | $56.85 Million | $818.00K | 0.014x | -95.51% |
| 2019-12-31 | $19.65 Million | $6.30 Million | 0.321x | -68.30% |
| 2018-12-31 | $9.30 Million | $9.41 Million | 1.012x | -39.95% |
| 2017-12-31 | $4.90 Million | $8.26 Million | 1.685x | +476.85% |
| 2016-12-31 | $-3.80 Million | $1.70 Million | -0.447x | -433.81% |
| 2015-12-31 | $-4.07 Million | $341.00K | -0.084x | +88.96% |
| 2014-12-31 | $-1.27 Million | $961.00K | -0.758x | -862.60% |
| 2013-12-31 | $4.85 Million | $-382.00K | -0.079x | -8.06% |
| 2012-12-31 | $12.05 Million | $-879.00K | -0.073x | -104.24% |
| 2011-12-31 | $10.14 Million | $-362.00K | -0.036x | +56.08% |
| 2010-12-31 | $8.18 Million | $-665.00K | -0.081x | -116.68% |
| 2009-12-31 | $7.49 Million | $3.65 Million | 0.487x | +425.29% |
| 2008-12-31 | $4.77 Million | $-715.16K | -0.150x | -172.56% |
| 2007-12-31 | $3.62 Million | $746.86K | 0.206x | +154.98% |
| 2006-12-31 | $1.29 Million | $-483.46K | -0.376x | +23.75% |
| 2005-12-31 | $440.77K | $-217.06K | -0.492x | +90.58% |
| 2004-12-31 | $202.89K | $-1.06 Million | -5.229x | -25607.87% |
| 2003-12-31 | $-461.11K | $-9.45K | 0.021x | -98.71% |
| 2000-12-31 | $-594.94K | $-945.18K | 1.589x | -- |
About Zynex Inc
Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain, and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) dev… Read more